Aminoglycoside-resistant Aeromonas hydrophila as part of a polymicrobial infection following a traumatic fall into freshwater

Joshua R. Shak, Jennifer A. Whitaker, Bruce S. Ribner, Eileen M. Burd

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Amikacin is a first-line treatment for Aeromonas infection due to high efficacy. There are few reports of aminoglycoside-resistant Aeromonas spp. We report a soft tissue infection containing multiple pathogens, including a strain of Aeromonas hydrophila resistant to amikacin, tobramycin, and multiple cephalosporins.

Original languageEnglish (US)
Pages (from-to)1169-1170
Number of pages2
JournalJournal of Clinical Microbiology
Volume49
Issue number3
DOIs
StatePublished - Mar 2011
Externally publishedYes

Fingerprint

Aeromonas hydrophila
Aeromonas
Amikacin
Aminoglycosides
Fresh Water
Coinfection
Soft Tissue Infections
Tobramycin
Cephalosporins
Infection

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Aminoglycoside-resistant Aeromonas hydrophila as part of a polymicrobial infection following a traumatic fall into freshwater. / Shak, Joshua R.; Whitaker, Jennifer A.; Ribner, Bruce S.; Burd, Eileen M.

In: Journal of Clinical Microbiology, Vol. 49, No. 3, 03.2011, p. 1169-1170.

Research output: Contribution to journalArticle

Shak, Joshua R. ; Whitaker, Jennifer A. ; Ribner, Bruce S. ; Burd, Eileen M. / Aminoglycoside-resistant Aeromonas hydrophila as part of a polymicrobial infection following a traumatic fall into freshwater. In: Journal of Clinical Microbiology. 2011 ; Vol. 49, No. 3. pp. 1169-1170.
@article{db27d2644b9e4dcbacb11ec7a74a925b,
title = "Aminoglycoside-resistant Aeromonas hydrophila as part of a polymicrobial infection following a traumatic fall into freshwater",
abstract = "Amikacin is a first-line treatment for Aeromonas infection due to high efficacy. There are few reports of aminoglycoside-resistant Aeromonas spp. We report a soft tissue infection containing multiple pathogens, including a strain of Aeromonas hydrophila resistant to amikacin, tobramycin, and multiple cephalosporins.",
author = "Shak, {Joshua R.} and Whitaker, {Jennifer A.} and Ribner, {Bruce S.} and Burd, {Eileen M.}",
year = "2011",
month = "3",
doi = "10.1128/JCM.01949-10",
language = "English (US)",
volume = "49",
pages = "1169--1170",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Aminoglycoside-resistant Aeromonas hydrophila as part of a polymicrobial infection following a traumatic fall into freshwater

AU - Shak, Joshua R.

AU - Whitaker, Jennifer A.

AU - Ribner, Bruce S.

AU - Burd, Eileen M.

PY - 2011/3

Y1 - 2011/3

N2 - Amikacin is a first-line treatment for Aeromonas infection due to high efficacy. There are few reports of aminoglycoside-resistant Aeromonas spp. We report a soft tissue infection containing multiple pathogens, including a strain of Aeromonas hydrophila resistant to amikacin, tobramycin, and multiple cephalosporins.

AB - Amikacin is a first-line treatment for Aeromonas infection due to high efficacy. There are few reports of aminoglycoside-resistant Aeromonas spp. We report a soft tissue infection containing multiple pathogens, including a strain of Aeromonas hydrophila resistant to amikacin, tobramycin, and multiple cephalosporins.

UR - http://www.scopus.com/inward/record.url?scp=79952318012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952318012&partnerID=8YFLogxK

U2 - 10.1128/JCM.01949-10

DO - 10.1128/JCM.01949-10

M3 - Article

C2 - 21209173

AN - SCOPUS:79952318012

VL - 49

SP - 1169

EP - 1170

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 3

ER -